Why it matters
Hair transplant surgery moves hair; it does not stop hair loss
A transplant redistributes donor hair. It cannot stop ongoing genetic, hormonal, inflammatory, traction-related, or medical hair loss. That is why diagnosis and stabilisation can be as important as graft count.
- Active thinning can make a strong hairline look isolated later.
- Medical treatment may reduce pressure on limited donor supply for some patients.
- Surgery should be planned around likely future loss, not only current gaps.
- A conservative first session may protect long-term options.
Diagnosis first
Not all hair loss is suitable for immediate transplant surgery
Patients should understand whether their loss is androgenetic alopecia, diffuse thinning, traction alopecia, scarring alopecia, alopecia areata, shedding, or another cause. Some patterns need medical evaluation before surgery is considered.
- Patchy loss can suggest causes that are not transplant-first problems.
- Inflamed or scarring scalp disease needs specialist assessment.
- Female-pattern and diffuse loss may need closer donor and diagnosis review.
- Sudden shedding should not be treated like stable pattern baldness.
Minoxidil
When minoxidil should be discussed before surgery
Minoxidil is commonly discussed for pattern hair loss. It may support existing hair in suitable patients, but it requires regular use, realistic expectations, and monitoring for irritation or adherence problems.
- Ask whether minoxidil is appropriate before or after surgery.
- Ask how long a trial should run before judging response.
- Ask whether scalp irritation changes the plan.
- Ask how stopping treatment could affect future shedding.
Finasteride
When finasteride should be discussed before surgery
Finasteride is often discussed for male pattern hair loss, but it needs prescription-level counselling. Benefits, side effects, sexual health, mood history, fertility plans, and long-term adherence should be reviewed before relying on it in a transplant plan.
- Ask about expected benefit and uncertainty for your stage of loss.
- Ask about side effects and what to do if they occur.
- Ask who monitors treatment while you are in the UK or Ireland.
- Do not start or stop prescription medicine casually around travel.
PRP and adjuncts
PRP may be an adjunct, not a substitute for proper planning
PRP may be discussed before or after surgery for selected patients. It should not distract from diagnosis, donor mapping, hairline design, medication review, and realistic expectations.
- Ask what PRP is expected to support in your case.
- Ask how many sessions are proposed and at what interval.
- Ask whether maintenance sessions are expected.
- Ask whether PRP is optional, recommended, or not relevant for your diagnosis.
Travel and medicines
Medicine plans should be written before UK-to-Turkey travel
Patients should not change medicines only because flights, deposits, or package timing are fixed. The pre-op plan should state which medicines continue, pause, or need clinician sign-off.
- Tell the clinic about blood thinners, supplements, allergies, diabetes, blood pressure, and recent illness.
- Keep prescriptions and medicine names in your travel document pack.
- Check travel insurance before travelling for planned elective surgery.
- Ask what would trigger postponement, retesting, or medical clearance.
Booking decision
When surgery may still be appropriate
Surgery may be appropriate when diagnosis, donor capacity, medical history, expectations, and travel logistics are aligned. A good plan may combine conservative design, medical treatment, and future-stage planning rather than trying to solve every area at once.
- Ask if the design remains natural if future thinning continues.
- Ask whether medicine could protect non-transplanted hair.
- Ask whether the graft plan preserves future donor options.
- Ask what happens if medical treatment is declined or unsuitable.
